Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous t-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome)
Titel:
Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous t-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome)
Auteur:
Dummer, R. Duvic, M. Scarisbrick, J. Olsen, E.A. Rozati, S. Eggmann, N. Goldinger, S.M. Hutchinson, K. Geskin, L. Illidge, T.M. Giuliano, E. Elder, J. Kim, Y.H.